| 12 |
Systemic Therapy for Plaque Stabilization: New Drugs Targeting LP-PLA2 |
Patrick W. Serruys |
Jul. 22. 09 |
| 11 |
Plaque Stabilization and Regression After Statin Therapy Evaluated With Both Intravascular Ultrasound and Coronary Angioscope |
Junko Honye |
Oct. 10. 08 |
| 10 |
Novel HDL Targeted Therapies: The Search Continues, ... |
Karam Maximilian Kostner |
Jul. 04. 08 |
| 9 |
Torcetrapib's Failure: Find More Stories in the ILLUMINATE Trial |
Mats Eriksson |
Jul. 04. 08 |
| 8 |
Cutting-Edge Lipid Therapy, Clinical Updates |
Ki Hoon Han |
Jul. 04. 08 |
| 7 |
Regression: An Evidence-Based Assessment |
Cheol Whan Lee |
Jul. 04. 08 |
| 6 |
Biochemical Surrogate: Is It Valuable for Risk Stratification? |
James Kuang-Jan Liao |
Jul. 04. 08 |
| 5 |
In-Depth Review of CV Outcomes Through Statin Treatment Based on ALPS |
Dong-Ju Choi |
Nov. 23. 07 |
| 4 |
Role of Statin: Optimal Treatment for PCI Patients |
Sang-Hak Lee |
Nov. 23. 07 |
| 3 |
Achieving the Superior Treatment Goal for Patients at Risks Through Powerful Inhibition of Two Sources of Cholesterol -"VYTAL Study" |
Szilard Voros |
Nov. 09. 07 |
